Trial intelligence / Profile preview

Oxytocin to Enhance Alcohol Behavioral Couple Therapy

NCT03846505Phase 2Completed

Sponsor
Medical University of South Carolina
Start
May 2019
Primary completion
Jan 2024
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Oxytocin + ABCT with Placebo + ABCT (2 arms). Primary endpoints: Change in Percent Days Abstinent at 12 weeks, Change in Relationship Functioning at 12 weeks and 1 more. Started May 2019; status: completed.

02

Drugs

oxytocin
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT03846505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03846505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call